Subscribe to RSS
DOI: 10.1055/s-0038-1656331
Peritoneal Fluid and Plasma Fibrinolytic Activity in Women with Pelvic Inflammatory Disease
Publication History
Received 12 December 1991
Accepted after revision 26 February 1992
Publication Date:
03 July 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199202/lookinside/thumbnails/10-1055-s-0038-1656331-1.jpg)
Summary
Previous studies have shown that the fibrinolytic activity of peritoneum is depressed in local inflammation. We measured fibrinolytic parameters in peritoneal fluid and in plasma of 10 women with pelvic inflammatory disease (PID). Nine women, in whom laparoscopy for sterilisation was performed, served as a control group.
In the peritoneal fluid of women with PID, PAI-Ag, t-PA-Ag and u-PA-Ag were many times higher than in the control group. In contrast to the antigens which may be present in inert complexes, the potentially active compounds, measured as t-PA activity and plasmin-activable scu-PA, were not significantly different in the two groups, and in none of the samples was the active enzyme tcu-PA detectable. Nevertheless, the mean peritoneal fluid TDP and FbDP concentrations were about twenty times higher in the PID group than in the control group. In plasma of PID patients, none of the parameters except u-PA-Ag differed from those in the control group. The difference between control and patient plasma u-PA-Ag was statistically significant, but too small to attach any relevance to the observation.
Our data suggest that, in contrast to the classical concept of decreased fibrinolytic activity as a cause of adhesion formation, intraperitoneal fibrinolysis is enhanced in peritoneal inflammation through stimulation of the local production of t-PA and u-PA. Despite concomitant production of PAI, fibrinolysis occurs at a high rate, resulting in high levels of fibrin degradation products. Since this activated fibrinolysis does not meet the demand, therapeutic enhancement should be considered to prevent adhesions.
-
References
- 1 Weström L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138: 880-892
- 2 Heinonen PK, Teisala K, Punnonen R, Miettenen A, Lehtinen M, Pavoonen J. Anatomic sites of upper genital tract infection. Obstet Gynecol 1985; 66: 384-390
- 3 Centers for Disease Control Pelvic inflammatory disease: United States. MMWR 1980 28. 605-607
- 4 World Health Organisation Non gonococcal urethritis and other sexually transmitted diseases of public health importance. WHO Tech RepSer 1981 660. 98-100
- 5 Brosens IA, Gordon AG. The abnormal fallopian tube. In: Tubal Infertility. Gower Medical Publishing; London: 1989: 2.2-2.33
- 6 Woodruff JD, Pauerstein CJ. The Fallopian Tube. Structure, Function, Pathology and Management. The Williams and Wilkins Co.; Baltimore, MD: 1969
- 7 Weström L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121: 707-713
- 8 Ellis H, Harrison W, Hugh TB. The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 52: 471-476
- 9 Myhre-Jensen O, Bergman-Larsen S, Astrup T. Fibrinolytic activity in serosal and synovial membranes. Arch Pathol 1969; 88: 623-630
- 10 Porter JM, Mc Gregor Jr F, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969; 20: 80-82
- 11 Hau T, Payne WD, Simmons RL. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 1979; 148: 415-418
- 12 Jacobson L, Weström L. Objectivized diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol 1969; 1088-1098
- 13 Wølner-Hanssen P, Mårdh PE, Svensson L, Weström L. Laparoscopy in women with chlamydial infection and pelvic pain: A comparison with and without salpingitis. Obstet Gynecol 1983; 61: 299-303
- 14 Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983; 61: 113-114
- 15 Vemer HM, Colla P, Schoot DC, Willemsen WNP, Bierkens PB, Rolland R. Women regretting their sterilization. Fertil Steril 1986; 46: 724-726
- 16 Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; 1: 153-156
- 17 Kirchheimer J, Binder BR. Urokinase antigen in plasma: age and sex dependent variations. Thromb Res 1984; 36: 643-646
- 18 Verheijen JH, Chang CTG, Kluft C. Evidence for the occurrence of a fast acting inhibitor of tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
- 19 Binnema D, Van Iersel JJL, Dooijewaard G. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 1986; 43: 569-577
- 20 Hinsbergh v VWM, Berg vd EA, Fiers W, Dooijewaard G. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990; 75: 1991-1998
- 21 Thompson JN, Paterson-Brown S, Harbourne T, Whawell SA, Kalodki E, Dudley HAF. Reduced human plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989; 76: 382-384
- 22 Vipond MN, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990; 335: 1120-1122
- 23 Ellis H. The aetiology of post-operative abdominal adhesions. An experimental study. Br J Surg 1962; 50: 10-16
- 24 Ryan GB, Grobety J, Majno G. Postoperative peritoneal adhesions. A study of the mechanisms. Am J Pathol 1971; 65: 117-140
- 25 Colucci M, Paramo JA, Stasse JM, Collen D. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components. J Clin Invest 1986; 78: 138-144
- 26 Kooistra T, Bosma PJ, Jespersen J, Kluft C. Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables. Am J Obstet Gynecol 1990; 163: 404-412
- 27 Hinsberg v VWM, Kooistra T, Scheffer MA, Bockel v JH, Muijen v GNP. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-1497
- 28 Grøndahl-Hansen KirkebyLT, Ralfkiaer E, Kristensen P, Lund LR, Danø K. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix. Am J Pathol 1989; 135: 631-636
- 29 de Bruin PAF, Crama-Bohbouth G, Verspaeget HW, Verheijen JH, Dooijewaard G, Weterman IT, Lamers CBHW. Plasminogen activators in the intestine of patients with inflammatory bowel disease. Thromb Haemostas 1988; 60: 262-266
- 30 Brommer EJP, Dooijewaard G, Dijkmans BAC, Breedveld FC. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Submitted for publication
- 31 Albrechtsen OK. The fibrinolytic activity of human tissues. Br J Haematol 1957; 3: 284-291
- 32 Astrup T, Beller FK, Glas P, Rasmussen J. Fibrinolytic activity of the human uterine tube. Obstet Gynecol 1965; 25: 853-857
- 33 Buckman RF, Woods M, Sargent L, Gervin AS. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976; 20: 1-5
- 34 Raftery AT. Regeneration of peritoneum: A fibrinolytic study. J Anat 1979; 3: 659-664
- 35 Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. An experimental study in the rat. Eur Surg Res 1981; 13: 397-401
- 36 Menziez D, Ellis H. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator. J R Soc Med 1989; 82: 534-535
- 37 McRitchie DI, Cummings D, Rotstein OD. Delayed administration of tissue plasminogen activator reduces intra-abdominal abscess formation. Arch Surg 1989; 124: 1406-1410
- 38 Dörr PJ, Vemer HM, Brommer EJP, Willemsen WNP, Veldhuizen RW, Rolland R. Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit. Eur J Obstet Gynecol Reprod Biol 1990; 37: 287-291